Restricted accessEditorialFirst published online 2015-8
Reply To the Editor,Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract,published online September 2014. DOI: 10.1177/1078155214551315
BrodskáHMalíčkováKŠtastnáMM. Pitfalls in the laboratory assessment of serum prealbumin levels in hemato-oncological patients. Clin Lab2014; 60: 1937–1941.
2.
LiuLLiuJDaiS. Reduced transthyretin expression in sera of lung cancer. Cancer Sci2007; 98: 1617–1624.
3.
ClarkeCHYipCBadgwellD. Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer. Gynecol Oncol2011; 122: 548–553.
4.
MooreLEFungETMcGuireM. Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiol Biomarkers Prev2006; 15: 1641–1646.
5.
IharaHMatsumotoTShinoY. Selective use of transthyretin and retinol-binding protein as markers in the postoperative assessment of protein nutritional status. J Clin Lab Anal2003; 17: 1–5.
6.
Sobotka L. Basics of clinical nutrition, 3rd ed. 2004 ISBN: 80-7262-292-7.
